Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

LL-37

Cathelicidin, hCAP-18, FALL-39, CAP-18

Quick Stats
Studies 2230
Trials 95
Score 1
2018 pubmed 96 citations

Pseudomonas aeruginosa rugose small-colony variants evade host clearance, are hyper-inflammatory, and persist in multiple host environments.

Pestrak. Matthew J MJ; Chaney. Sarah B SB; Eggleston. Heather C HC; Dellos-Nolan. Sheri S; Dixit. Sriteja S; Mathew-Steiner. Shomita S SS; Roy. Sashwati S; Parsek. Matthew R MR; Sen. Chandan K CK; Wozniak. Daniel J DJ

Key Findings

  • RSCV infections cause strong neutrophil influx, high ROS production, and severe tissue damage.
  • These bacterial variants evade being eaten by neutrophils and form protective aggregates.
  • RSCVs are more tolerant to the antimicrobial peptide LL‑37 than normal bacteria.

Practical Outcomes

  • For DIY health enthusiasts, the study suggests that relying on LL‑37 (or similar antimicrobial peptides) to fight chronic Pseudomonas infections may be ineffective against these rugged bacterial forms. It highlights the need to explore other anti‑biofilm strategies or combination therapies rather than counting on LL‑37 alone.

Summary

A special, highly sticky form of the bacteria Pseudomonas aeruginosa (called RSCV) triggers a big but useless immune reaction, damages tissue, and can survive attacks from the body's own antimicrobial peptide LL‑37.

Abstract

Pseudomonas aeruginosa causes devastating infections in immunocompromised individuals. Once established, P. aeruginosa infections become incredibly difficult to treat due to the development of antibiotic tolerant, aggregated communities known as biofilms. A hyper-biofilm forming clinical variant of P. aeruginosa, known as a rugose small-colony variant (RSCV), is frequently isolated from chronic infections and is correlated with poor clinical outcome. The development of these mutants during infection suggests a selective advantage for this phenotype, but it remains unclear how this phenotype promotes persistence. While prior studies suggest RSCVs could survive by evading the host immune response, our study reveals infection with the RSCV, PAO1ΔwspF, stimulated an extensive inflammatory response that caused significant damage to the surrounding host tissue. In both a chronic wound model and acute pulmonary model of infection, we observed increased bacterial burden, host tissue damage, and a robust neutrophil response during RSCV infection. Given the essential role of neutrophils in P. aeruginosa-mediated disease, we investigated the impact of the RSCV phenotype on neutrophil function. The RSCV phenotype promoted phagocytic evasion and stimulated neutrophil reactive oxygen species (ROS) production. We also demonstrate that bacterial aggregation and TLR-mediated pro-inflammatory cytokine production contribute to the immune response to RSCVs. Additionally, RSCVs exhibited enhanced tolerance to neutrophil-produced antimicrobials including H2O2 and the antimicrobial peptide LL-37. Collectively, these data indicate RSCVs elicit a robust but ineffective neutrophil response that causes significant host tissue damage. This study provides new insight on RSCV persistence, and indicates this variant may have a critical role in the recurring tissue damage often associated with chronic infections.

Study Information

Provider

pubmed

Year

2018

Date

2018-02-02T00:00:00.000Z

DOI

10.1371/journal.ppat.1006842

Citations

96

References

76